Chuck Royce's TLSI Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 200,060 shares of TriSalus Life Sciences, Inc. (TLSI) worth $800,240, representing 0.01% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in TLSI, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's TriSalus Life Sciences (TLSI) Holding Value Over Time
Track share changes against reported price movement
Quarterly TriSalus Life Sciences (TLSI) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +200,060 | New Buy | 200,060 | $4.00 |
Chuck Royce's TriSalus Life Sciences Investment FAQs
Chuck Royce first purchased TriSalus Life Sciences, Inc. (TLSI) in Q1 2026, acquiring 200,060 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held TriSalus Life Sciences, Inc. (TLSI) for 1 quarters since Q1 2026.
Chuck Royce's largest addition to TriSalus Life Sciences, Inc. (TLSI) was in Q1 2026, adding 200,060 shares worth $800,240.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 200,060 shares of TriSalus Life Sciences, Inc. (TLSI), valued at approximately $800,240.
As of the Q1 2026 filing, TriSalus Life Sciences, Inc. (TLSI) represents approximately 0.01% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in TriSalus Life Sciences, Inc. (TLSI) was 200,060 shares, as reported at the end of Q1 2026.